SMPDL3B and metabolic dysfunction-associated steatotic liver disease: Moreover, macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease through suppressing the expression of SMPDL3B (Gwag et al., 2021).